Showing results (21-30 of 178) with videos related to

Sort By:
Pageof 18
Autoimmunity|September 4, 2015
miRNA-29a in systemic sclerosis: A valid targetSteven O'Reilly
Clinical Science (London, England : 1979)|November 14, 2014
Pound the alarm: danger signals in rheumatic diseasesSteven O'Reilly
Rheumatology (Oxford, England)|July 21, 2022
Toll-like receptor triggering in systemic sclerosis: time to targetSteven O'Reilly
Journal of Molecular Medicine (Berlin, Germany)|February 22, 2024
Emerging therapeutic targets in systemic sclerosisSteven O'Reilly
Arthritis Research & Therapy|January 15, 2016
MicroRNAs in fibrosis: opportunities and challengesSteven O'Reilly
Molecular Aspects of Medicine|October 11, 2016
Epigenetics in fibrosisSteven O'Reilly
Cytokine|June 6, 2022
Interleukin-36α is elevated in diffuse systemic sclerosis and may potentiate fibrosisSteven O'Reilly
Rheumatology (Oxford, England)|March 27, 2018
Epigenetic modulation as a therapy in systemic sclerosisSteven O'Reilly
Matrix Biology : Journal of the International Society for Matrix Biology|January 14, 2024
S100A4 a classical DAMP as a therapeutic target in fibrosisSteven O'Reilly
Clinical and Experimental Rheumatology|February 18, 2012
Prevalence, prognosis, and factors associated with left ventricular diastolic dysfunction in systemic sclerosisMonique Hinchcliff, Chintan S Desai, John Varga, et al.
Pageof 18